Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma-Reference-Cited by-同舟云学术

Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma

Published:2022-01-27 Issue:4 Volume:386 Page:351-363
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Tilly Hervé¹,Morschhauser Franck¹,Sehn Laurie H.¹,Friedberg Jonathan W.¹,Trněný Marek¹,Sharman Jeff P.¹,Herbaux Charles¹,Burke John M.¹,Matasar Matthew¹,Rai Shinya¹^ORCID,Izutsu Koji¹,Mehta-Shah Neha¹,Oberic Lucie¹,Chauchet Adrien¹,Jurczak Wojciech¹,Song Yuqin¹,Greil Richard¹,Mykhalska Larysa¹,Bergua-Burgués Juan M.¹,Cheung Matthew C.¹,Pinto Antonio¹,Shin Ho-Jin¹,Hapgood Greg¹,Munhoz Eduardo¹,Abrisqueta Pau¹,Gau Jyh-Pyng¹,Hirata Jamie¹,Jiang Yanwen¹,Yan Mark¹,Lee Calvin¹,Flowers Christopher R.¹,Salles Gilles¹^ORCID

Affiliation:

1. From the Department of Hematology and INSERM Unité 1245, Centre Henri-Becquerel and University of Rouen, Rouen (H.T.), Université de Lille, Centre Hospitalier Universitaire (CHU) Lille, ULR 7365 – GRITA – Groupe de Recherche sur les Formes Injectables et les Technologies Associées, Lille (F.M.), CHU de Montpellier, Montpellier (C.H.), the Department of Hematology, Institut Universitaire du Cancer, Toulouse–Oncopole, Toulouse (L.O.), and the Department of Hematology, Centre Hospitalier Régional...

Funder

F. Hoffmann-La Roche Ltd

Genentech, Inc

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa2115304

Cited by 261 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemical Strategies towards the Development of Effective Anticancer Peptides;Current Medicinal Chemistry;2024-04

2. Navigating between Scylla and Charybdis: A roadmap to do better than Pola-RCHP in DLBCL;Cancer Treatment Reviews;2024-03

3. An evaluation of glofitamab, the first fixed-duration bispecific antibody for relapsed or refractory large B-cell lymphomas;Expert Opinion on Biological Therapy;2024-02-02

4. The Non-hodgkin Lymphoma Treatment and Side Effects: A Systematic Review and Meta-analysis;Recent Patents on Anti-Cancer Drug Discovery;2024-02

5. Tafasitamab for the treatment of patients with diffuse large B-cell lymphoma;Human Vaccines & Immunotherapeutics;2024-02